Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment

The early diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI) is very important for treatment research and patient care purposes. Few biomarkers are currently considered in clinical settings, and their use is still optional. The objective of this work was to determine whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Torteya, Antonio, Treviño, Víctor, Tamez-Peña, José G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464003/
https://www.ncbi.nlm.nih.gov/pubmed/26106620
http://dx.doi.org/10.1155/2015/961314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464003/
https://www.ncbi.nlm.nih.gov/pubmed/26106620
http://dx.doi.org/10.1155/2015/961314

Ejemplares similares